These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38980027)

  • 1. Evaluation of Xpert point-of-care assays for detection of HIV infection in persons using long-acting cabotegravir for pre-exposure prophylaxis.
    Fogel JM; Piwowar-Manning E; Moser A; Hill T; Ahmed S; Cummings V; Mostafa HH; Wang Z; Jennings A; Gallardo-Cartagena JA; Figueroa MI; St Clair M; Rinehart AR; Adeyeye A; Rooney JF; Cohen MS; Grinsztejn B; Landovitz RJ; Eshleman SH;
    Microbiol Spectr; 2024 Jul; ():e0030724. PubMed ID: 38980027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Accuracy of the Rapid Xpert HIV-1 Viral Load XC, Xpert HIV-1 Viral Load, & m-PIMA HIV-1/2 Viral Load in South African Clinics.
    Dorward J; Naidoo J; Moodley P; Sookrajh Y; Samsunder N; Sayed F; Naicker N; Fanshawe T; Drain PK; Lessells RJ; Hayward G; Butler CC; Garrett N
    J Acquir Immune Defic Syndr; 2022 Oct; 91(2):189-196. PubMed ID: 36094486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV RNA Screening Reduces Integrase Strand Transfer Inhibitor Resistance Risk in Persons Receiving Long-Acting Cabotegravir for HIV Prevention.
    Eshleman SH; Fogel JM; Halvas EK; Piwowar-Manning E; Marzinke MA; Kofron R; Wang Z; Mellors J; McCauley M; Rinehart AR; St Clair M; Adeyeye A; Hinojosa JC; Cabello R; Middelkoop K; Hanscom B; Cohen MS; Grinsztejn B; Landovitz RJ;
    J Infect Dis; 2022 Dec; 226(12):2170-2180. PubMed ID: 36240386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance assessment of the new Xpert® HIV-1 viral load XC assay for quantification of HIV-1 viral loads.
    Ehret R; Harb K; Breuer S; Obermeier M
    J Clin Virol; 2022 Apr; 149():105127. PubMed ID: 35305378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the performance of Aptima HIV-1 Quant Dx Assay with Abbott RealTime HIV Assay for viral load monitoring using plasma and Dried Blood Spots collected in Kenya.
    Mwau M; Schaffer S; Kimani H; Kasiano P; Ogolla F; Ajema E; Adoyo S; Nyairo E; Saleri N; Nair SV
    PLoS One; 2022; 17(8):e0269838. PubMed ID: 35994447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next-generation point-of-care testing in pediatric human immunodeficiency virus infection facilitates diagnosis and monitoring of treatment.
    Bengu N; Mchunu N; Mokhethi S; Fillis R; Cromhout G; Lobenstein JV; Graza Y; Kapongo C; Chinniah K; Bhoola R; Adland E; Puertas MC; Ndung'u T; Martinez-Picado J; Archary M; Goulder PJR
    Medicine (Baltimore); 2022 Jul; 101(27):e29228. PubMed ID: 35801794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the RealTime HIV-1, Xpert HIV-1, and Aptima HIV-1 Quant Dx Assays in Comparison to the NucliSens EasyQ HIV-1 v2.0 Assay for Quantification of HIV-1 Viral Load.
    Mor O; Gozlan Y; Wax M; Mileguir F; Rakovsky A; Noy B; Mendelson E; Levy I
    J Clin Microbiol; 2015 Nov; 53(11):3458-65. PubMed ID: 26292298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the point-of-care (POC) technologies Xpert HIV-1 Qual and m-PIMA HIV 1/2 detect for early diagnosis of HIV-1 and HIV-2 in Senegal.
    Ndoye AS; Ndiaye HD; Diallo M; Diack A; Coulibaly K; Lo G; Kiernan B; Sène PY; Ndiaye O; Ngom NF; Fall M; Diop K; Gueye SB; Dieng A; Lejeune C; Ndour CT; Kane CT
    Pan Afr Med J; 2022; 43():42. PubMed ID: 36523274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Human Immunodeficiency Virus (HIV) Infection in Cisgender Men and Transgender Women Who Have Sex With Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083.
    Marzinke MA; Grinsztejn B; Fogel JM; Piwowar-Manning E; Li M; Weng L; McCauley M; Cummings V; Ahmed S; Haines CD; Bushman LR; Petropoulos C; Persaud D; Adeyeye A; Kofron R; Rinehart A; St Clair M; Rooney JF; Pryluka D; Coelho L; Gaur A; Middelkoop K; Phanuphak N; Cohen MS; Hendrix CW; Anderson P; Hanscom B; Donnell D; Landovitz RJ; Eshleman SH
    J Infect Dis; 2021 Nov; 224(9):1581-1592. PubMed ID: 33740057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter Evaluation of Two Next-Generation HIV-1 Quantitation Assays, Aptima Quant Dx and Cobas 6800, in Comparison to the RealTi
    Wiesmann F; Ehret R; Naeth G; Däumer M; Fuhrmann J; Kaiser R; Noah C; Obermeier M; Schalasta G; Tiemann C; Wolf E; Knechten H; Braun P
    J Clin Microbiol; 2018 Oct; 56(10):. PubMed ID: 30068537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective evaluation of accuracy of HIV viral load monitoring using the Aptima HIV Quant Dx assay with fingerstick and venous dried blood spots prepared under field conditions in Kenya.
    Mwau M; Danda J; Mbugua J; Handa A; Fortunko J; Worlock A; Nair SV
    PLoS One; 2021; 16(4):e0249376. PubMed ID: 33798221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review of the performance and clinical utility of point of care HIV-1 RNA testing for diagnosis and care.
    Agutu CA; Ngetsa CJ; Price MA; Rinke de Wit TF; Omosa-Manyonyi G; Sanders EJ; Graham SM
    PLoS One; 2019; 14(6):e0218369. PubMed ID: 31246963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the Aptima HIV-1 Quant Dx assay with the COBAS AmpliPrep/COBAS TaqMan HIV-1 v2.0 Test for HIV-1 viral load quantification in plasma samples from HIV-1-infected patients.
    Longo S; Bon I; Musumeci G; Bertoldi A; D'Urbano V; Calza L; Re MC
    Health Sci Rep; 2018 Apr; 1(4):e31. PubMed ID: 30623066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the Dual-Target Aptima HIV-1 Quant Dx Assay: Comparison between Viral Loads Measured with
    Sberna G; Sarti S; Cicalini S; Antinori A; Garbuglia AR; Amendola A
    Microbiol Spectr; 2022 Oct; 10(5):e0136122. PubMed ID: 36066258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the performance of the Cepheid Xpert HIV-1 Viral Load Assay for quantitative and diagnostic uses.
    Wesolowski L; Fowler W; Luo W; Sullivan V; Masciotra S; Smith T; Rossetti R; Delaney K; Oraka E; Chavez P; Ethridge S; Switzer WM; Owen SM
    J Clin Virol; 2020 Jan; 122():104214. PubMed ID: 31835210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy and Operational Characteristics of Xpert Human Immunodeficiency Virus Point-of-Care Testing at Birth and Until Week 6 in Human Immunodeficiency Virus-exposed Neonates in Tanzania.
    Sabi I; Mahiga H; Mgaya J; Geisenberger O; Kastner S; Olomi W; Saathoff E; Njovu L; Lueer C; France J; Maboko L; Ntinginya NE; Hoelscher M; Kroidl A
    Clin Infect Dis; 2019 Feb; 68(4):615-622. PubMed ID: 29961841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility Of POC Xpert HIV-1 Tests For Detection-Quantification Of Complex HIV Recombinants Using Dried Blood Spots From Kinshasa, D. R. Congo.
    Rubio-Garrido M; Ndarabu A; Reina G; Barquín D; Fernández-Alonso M; Carlos S; Holguín Á
    Sci Rep; 2019 Apr; 9(1):5679. PubMed ID: 30952893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Point-of-care viral load tests to detect high HIV viral load in people living with HIV/AIDS attending health facilities.
    Ochodo EA; Olwanda EE; Deeks JJ; Mallett S
    Cochrane Database Syst Rev; 2022 Mar; 3(3):CD013208. PubMed ID: 35266555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-site clinical evaluation of the Xpert(®) HIV-1 viral load assay.
    Jordan JA; Plantier JC; Templeton K; Wu AH
    J Clin Virol; 2016 Jul; 80():27-32. PubMed ID: 27135387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Acting Injectable Cabotegravir for HIV Preexposure Prophylaxis Among Sexual and Gender Minorities: Protocol for an Implementation Study.
    Grinsztejn B; Torres TS; Hoagland B; Jalil EM; Moreira RI; O'Malley G; Shade SB; Benedetti MR; Moreira J; Simpson K; Pimenta MC; Veloso VG;
    JMIR Public Health Surveill; 2023 Apr; 9():e44961. PubMed ID: 37074775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.